Benefits
Osteoarthritis pain and function
Clinical trials in knee osteoarthritis show modest improvements in pain and function with MSM supplementation. Effect sizes are smaller than NSAIDs but useful as adjunct support, particularly when combined with glucosamine and chondroitin.
Exercise-induced muscle damage reduction
Trials in physically active adults show reduced markers of muscle damage and inflammation following intense exercise with MSM supplementation. Practical for athletes wanting natural recovery support.
Sulfur for connective tissue
MSM provides bioavailable sulfur required for joint cartilage, collagen, and other connective tissues. Mechanism contributes to its joint health applications and supports overall structural tissue maintenance.
Anti-inflammatory effects
MSM supplementation reduces some inflammatory markers (CRP, IL-6) in adults with chronic mild inflammation. Effects are modest but consistent across trials — supportive anti-inflammatory action.
Skin, hair, and nail support
Sulfur is a building block for keratin (hair and nails) and collagen (skin). Some clinical evidence supports skin elasticity and nail quality benefits with MSM supplementation over weeks of use.
Antioxidant glutathione synthesis
MSM-derived sulfur supports endogenous glutathione synthesis — the body's master antioxidant. Indirect antioxidant mechanism contributes to MSM's general supportive effects.
Combination with glucosamine and chondroitin
Combined with glucosamine and chondroitin, MSM produces stronger joint pain effects than any individual component alone in trials. The most evidence-based way to use MSM for OA applications.
Excellent safety and tolerability
Well-tolerated across long-term clinical trials with side effects no more frequent than placebo. Suitable for chronic use — an important consideration for ongoing joint health support where NSAID alternatives matter.
Mechanism of action
Sulfur donation
MSM provides bioavailable sulfur, used in synthesis of glutathione, methionine, cysteine, and sulfur-containing structural proteins (keratin, collagen). Supports antioxidant capacity via glutathione regeneration. Foundation for skin/hair/nail and antioxidant applications. Note: typical Western diets are not sulfur-deficient — supplementation provides marginal benefit in well-nourished adults.
Anti-inflammatory signaling
MSM modulates NF-κB signaling and reduces inflammatory cytokines (TNF-α, IL-6) in animal and small human studies. May reduce CRP at higher doses. Mechanism plausible but clinical effect sizes modest compared to mechanism-based predictions.
Antioxidant via glutathione support
MSM supports endogenous glutathione synthesis through cysteine donation. Glutathione is the primary intracellular antioxidant. May reduce exercise-induced and inflammatory oxidative stress markers.
Mucolytic activity (allergic rhinitis context)
MSM may have mild mucolytic effects, reducing mucus viscosity. Possible mechanism for upper respiratory symptom relief in seasonal allergic rhinitis. Not as well-characterized as anti-inflammatory mechanism.
Possible mast cell stabilization
Proposed mechanism for allergic rhinitis benefit — MSM may stabilize mast cells and reduce histamine release. Mechanism would explain symptom relief without sedation seen in MSM trials. Direct evidence from human studies limited; remains hypothetical.
Clinical trials
Evidence review and pooled analysis of MSM and DMSO for osteoarthritis pain.
Clinical population described in trial publication.
Evidence review and pooled analysis of MSM and DMSO for osteoarthritis pain. 3 high-quality clinical trials (2 DMSO, 1 MSM, total N=326). Pooled VAS pain reduction 6.34 mm (95% CI -0.49 to 13.17) — neither statistically nor clinically significant. Effect size 1.82. Major honesty correction to popular MSM-for-arthritis marketing — most rigorous meta-analytic evidence is null.
Single-blind clinical trial in 118 patients with mild-moderate knee OA.
118 patients with mild-moderate knee OA
Single-blind clinical trial in 118 patients with mild-moderate knee OA. Glucosamine sulfate 500mg vs MSM 500mg vs combination, three times daily × 12 weeks. Combination significantly more effective than either alone on WOMAC pain and functional scores. Used lower MSM dose than typical supplemental practice; results may underestimate full-dose effect.
Multicenter open-label trial in 50 subjects with SAR. MSM 2,600 mg/day × 30 days.
50 subjects with SAR
Multicenter open-label trial in 50 subjects with SAR. MSM 2,600 mg/day × 30 days. Significant reductions in upper respiratory symptoms (runny nose, congestion, sneezing) by day 7 (p<0.01). Lower respiratory symptoms also improved by week 3. Effects sustained throughout 30-day trial. Open-label design limits causal inference but signal substantial enough to motivate randomized follow-up.
Randomized double-blind exploratory study with standardized allergen challenge methodology.
Clinical population described in trial publication.
Randomized double-blind exploratory study with standardized allergen challenge methodology. Confirmed MSM provided significant relief of allergic rhinitis symptoms vs placebo. Objective measure: improved peak nasal inspiratory flow. Better-quality follow-up to the 2002 open-label trial; supports allergic rhinitis as the better-evidenced MSM application.
Double-blind randomized trial of topical silymarin + MSM cream vs vehicle in mild-moderate rosacea × 30 days.
Clinical population described in trial publication.
Double-blind randomized trial of topical silymarin + MSM cream vs vehicle in mild-moderate rosacea × 30 days. Improvements in papules, erythema, itching, skin hydration. Combination intervention — independent MSM contribution to effect unclear. Reasonable adjunct in supervised rosacea care.